Integras Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Integras Partners's AMGN Position: Q2 2026 in Review
Integras Partners increased its Amgen (AMGN) stake by 1.3% in Q2 2026, buying an estimated $42.1K and bringing the position to 9,675 shares worth $3.5M. The position accounts for 1.93% of the portfolio, ranked #17.
Integras Partners first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,540 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Integras Partners held 9,675 shares of Amgen worth $3.5M as of Q2 2026.
- Integras Partners bought 123 Amgen shares in Q2 2026, an estimated $42.1K.
- Amgen made up 1.93% of Integras Partners's portfolio in Q2 2026, its #17 holding.
- Integras Partners first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 1,540 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Integras Partners's 13F filing for Q2 2026, filed 24 Jul 2026.